Smallpox vaccine

Pediatrics

Volumn 110, Issue 4, 2002, Pages 841-845

  Abramson, Jon S ^a   Baker, Carol J ^a   Baltimore, Robert S ^a   Fisher, Margaret C ^a   McMillan, Julia A ^a   Meissner, H Cody ^a   Overturf, Gary D ^a   Powell, Keith R ^a   Prober, Charles G ^a   Rennels, Margaret B ^a   Saari, Thomas N ^a   Pickering, Larry K ^a   Ledbetter, Edgar O ^a   Cook, Martha ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

SMALLPOX VACCINE;

BIOLOGICAL WARFARE; DEATH; DRUG HYPERSENSITIVITY; DRUG INDICATION; ECZEMA; ENCEPHALITIS; ERADICATION THERAPY; HEALTH CARE POLICY; HUMAN; PREVALENCE; PRIORITY JOURNAL; REVIEW; RISK BENEFIT ANALYSIS; SIDE EFFECT; SMALLPOX; VACCINIA;

BIOTERRORISM; ETHICS, MEDICAL; HUMANS; IMMUNIZATION PROGRAMS; MASS IMMUNIZATION; ORGANIZATIONAL POLICY; PEDIATRICS; RISK FACTORS; SMALLPOX; SMALLPOX VACCINE; SOCIETIES, MEDICAL; UNITED STATES; WORLD HEALTH;

EID: 0141918924     PISSN: 00314005     EISSN: None     Source Type: Journal    
DOI: 10.1542/peds.110.4.841     Document Type: Review

References (18)

1. Koplan JP, Foster SO. Smallpox: clinical types, causes of death, and treatment. J Infect Dis. 1979;140:440-441
2. Alibek K. Biohazard: The Chilling True Story of the Largest Covert Biological Weapons Program in the World-Told From the Inside by the Man Who Ran It. New York, NY: Random House; 1999
3. Henderson DA, Inglesby TV, Bartlett JG, et al. Smallpox as a biological weapon: medical and public health management. JAMA. 1999;281: 2127-2137
4. O'Toole T. Smallpox: an attack scenario. Emerg Infect Dis. 1999;5: 540-546
5. Meltzer MI, Damon I, LeDuc JW, Millar JD. Modeling potential responses to smallpox as a bioterrorist weapon. Emerg Infect Dis. 2001;7: 959-969
6. Fauci AS. Smallpox vaccination policy-the need for dialogue. N Engl J Med. 2002;346:1319-1320
7. Breman JG, Henderson DA. Diagnosis and management of smallpox. N Engl J Med. 2002;346:1300-1308
8. Frey SE, Newman FK, Cruz J, et al. Dose-related effects of smallpox vaccine. N Engl J Med. 2002;346:1275-1280
9. Frey SE, Couch RB, Tacket CO, et al. Clinical responses to undiluted and diluted smallpox vaccine. N Engl J Med. 2002;346:1265-1274
10. Lane JM, Ruben FL, Neff JM, Millar JD. Complications of smallpox vaccination, 1968. N Engl J Med. 1969;281:1201-1208
11. Lane JM, Ruben FL, Neff JM, Millar JD. Complications of smallpox vaccination, 1968: results of ten statewide surveys. J Infect Dis. 1970;122: 303-309
12. Lane JM, Millar JD. Risks of smallpox vaccination complications in the United States. Am J Epidemiol. 1971;93:238-240
13. Rudikoff D, Lebwohl M. Atopic dermatitis. Lancet. 1998;351:1715-1721
14. Centers for Disease Control and Prevention. Vaccinia (smallpox) vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2001. MMWR Morb Mortal Wkly Rep. 2001;50(RR10):1-25
15. Pear R. A nation challenged: the bioterrorism threat. Frozen smallpox vaccine is still potent, officials say. The New York Times. March 30, 2002:A8
16. Bicknell WJ. The case for voluntary smallpox vaccination. N Engl J Med. 2002;346:1323-1325
17. Centers for Disease Control and Prevention, Public Health Emergency Preparedness and Response. Interim smallpox response plan and guidelines. Atlanta, GA: Centers for Disease Control and Prevention; November 2001. Available at: http://www.bt.cdc.gov/DocumentsApp/ Smallpox/RPG/index. asp. Accessed July 18, 2002
18. Koplan JP, Marton KI. Smallpox vaccination revisited. Some observations on the biology of vaccinia. Am J Trop Med Hyg. 1975;24:656-663